Mallinckrodt, China Resources Pharma To Promote Optiray X-Ray

Mallinckrodt Pharmaceuticals has partnered with China Resources Pharma to promote its Optiray™ (ioversol injection) x-ray contrast media in China.

AsianScientist (Nov. 26, 2013) – Mallinckrodt Pharmaceuticals has entered into a partnership with China Resources Pharmaceutical Co., Ltd. for the promotion of Optiray™ (ioversol injection) x-ray contrast media in China.

Optiray (ioversol injection) x-ray contrast media is a non-ionic, low viscosity iodine based contrast medium that is administered through intravascular routes to enhance diagnostic imaging procedures.

“Through this collaboration with China Resources Pharmaceutical, Mallinckrodt looks forward to increasing our ongoing commitment to grow sales of imaging products in the PRC,” said Stephen Merrick, President, International Commercial Operations at Mallinckrodt.

“Contrast media products to be covered under this agreement will be used for X-ray, computed tomography or cardiovascular procedures.”

——

Source: Mallinckrodt Pharmaceuticals.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist